Home / Cardiovascular system / Furosemide
ATC C03CA01 · Diuretics
Furosemide shortage
As of 31 Oct 2026, Furosemide has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 10 products.
Countries4/5
Products10packs or presentations
Short since10 Oct 202513 months ago
Earliest return2 Nov 2026company estimate
No return date7products
Main reasonManufacturing problem
Timeline
ItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | FUROSEMIDE FISIOPHARMA | FISIOPHARMA S.R.L. | 10 Oct 2025 | not given | Commercial decision or withdrawal Motivi commerciali: forniture discontinue |
| IT | FUROSEMIDE HEXAL | SANDOZ S.P.A. | 25 Mar 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LASIX | SANOFI S.R.L. | 31 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | FUROSEMIDE L.F.M. | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | 24 Aug 2026 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale ospedaliero) |
| IT | FUROSEMIDE L.F.M. | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | 22 Oct 2026 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale retail) |
| IT | FUROSEMIDE AUROBINDO announced | AUROBINDO PHARMA (ITALIA) S.R.L. | 16 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | FUROSEMIDA ALTAN 250mg/ 25ml SOLUCION PARA PERFUSION EFG 10 ampollas de 25 ml | Altan Pharmaceuticals Sa | 23 Mar 2026 | 16 Nov 2026 | Not stated |
| ES | SEGURIL 250 mg/25 ml SOLUCION INYECTABLE , 6 ampollas de 25 ml | Sanofi Aventis S.A. | 29 Oct 2026 | 10 Nov 2026 | Not stated |
| AT | Furon 40 mg - Tabletten, 50 Stück | Teva B.V. | 12 Oct 2026 | not given | Distribution or logistics Verzögerung bei der Auslieferung |
| BE | Lasix 250 mg/25 ml inf. sol. (conc.) i.v. amp. 6 x 25 ml | Sanofi Belgium | 16 Jun 2026 | 2 Nov 2026 | Manufacturing problem Delay in the release of the end product |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.